Lots of changes to the RVX website today

Toggle over all of the "Programs" sub-pages on the left menu of this page and you see that they have updated a lot of the content on the "Apabetalone/RVX-208 Clinical Development", "High-Risk Cardiovascular Disease", "Alzheimer's Disease", "Mechanism of Action", "Epigenetics", "BET Inhibition", and "BET Platform."

They've also updated their "Partnering" page: http://www.resverlogix.com/partnering/opportunities.html

They've also added a "Presentations and Publications" page:http://www.resverlogix.com/media/presentations-publications.html